IRIS
BUTTITTA, Fiamma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 213
NA - Nord America 83
AS - Asia 37
AF - Africa 3
SA - Sud America 2
Totale 338
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 122
US - Stati Uniti d'America 81
SE - Svezia 42
IE - Irlanda 16
VN - Vietnam 12
JP - Giappone 9
FR - Francia 7
GB - Regno Unito 5
CH - Svizzera 4
NL - Olanda 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IN - India 3
TR - Turchia 3
BR - Brasile 2
CA - Canada 2
ES - Italia 2
PH - Filippine 2
RU - Federazione Russa 2
TN - Tunisia 2
AT - Austria 1
CN - Cina 1
DE - Germania 1
DK - Danimarca 1
IR - Iran 1
KR - Corea 1
MA - Marocco 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
UA - Ucraina 1
Totale 338
Salva come PNG Salva come JPEG
Città #
Chieti 67
Stockholm 42
Dublin 16
Ashburn 12
Dong Ket 11
Boardman 5
Rome 5
Milan 4
Varallo 4
Cankaya 3
Fleming Island 3
Glasgow 3
Hartford 3
Messina 3
Niigata 3
Paris 3
Amsterdam 2
Ann Arbor 2
Bezons 2
Bologna 2
Brooklyn 2
East Falmouth 2
Houston 2
Las Palmas de Gran Canaria 2
Lausanne 2
Louisville 2
Napoli 2
Padova 2
Rieti 2
Saint-Basile-le-Grand 2
San Francisco 2
San Mateo 2
Takajomachi 2
Tappahannock 2
Yokohama 2
Andover 1
Aquila 1
Bacoli 1
Bangkok 1
Beijing 1
Belgrade 1
Brunico 1
Cambridge 1
Central 1
Cheyenne 1
Chuocho 1
Council Bluffs 1
Flushing 1
Hanoi 1
Hillsboro 1
Hyderabad 1
Karasawa 1
Kolkata 1
Lafayette 1
Lanciano 1
Laurel 1
Naga 1
Poulsbo 1
Redmond 1
Royal Tunbridge Wells 1
Salé 1
San Diego 1
San Jose 1
Spoltore 1
Tehran 1
Valduggia 1
Vienna 1
Wanchai 1
Wilmington 1
Worcester 1
Totale 260
Salva come PNG Salva come JPEG
Nome #
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm, file e4233f16-3c70-2860-e053-6605fe0a460a 94
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations., file e4233f14-f5b4-2860-e053-6605fe0a460a 41
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives, file e4233f17-7ea4-2860-e053-6605fe0a460a 28
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies, file e4233f17-7a4b-2860-e053-6605fe0a460a 19
Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: A case report, file e4233f16-2fa4-2860-e053-6605fe0a460a 18
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients, file e4233f18-8511-2860-e053-6605fe0a460a 17
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment, file e4233f17-11cb-2860-e053-6605fe0a460a 14
null, file e4233f15-4b1c-2860-e053-6605fe0a460a 10
Real-world data on NGS diagnostics: A survey from the Italian Society of Pathology (SIAPeC) NGS Network, file e4233f19-4dcd-2860-e053-6605fe0a460a 10
Identification of microRNAs 758 and 33b as potential modulators ofABCA1 expression in human atherosclerotic plaques, file e4233f19-5d71-2860-e053-6605fe0a460a 9
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays, file e4233f19-62ab-2860-e053-6605fe0a460a 9
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice, file e4233f17-7878-2860-e053-6605fe0a460a 8
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations, file e4233f19-164e-2860-e053-6605fe0a460a 8
Digital pathology and PD-L1 testing in non small cell lung cancer: A workshop record, file e4233f19-4f89-2860-e053-6605fe0a460a 8
POLE exonuclease domain mutations in endometrial carcinoma: a case report, file 65ee5822-d67b-4832-a947-82619f8c1ce2 7
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments, file e4233f18-ebd9-2860-e053-6605fe0a460a 6
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors, file e4233f19-2967-2860-e053-6605fe0a460a 6
BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories, file e4233f19-4f8a-2860-e053-6605fe0a460a 6
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm, file e4233f16-f5dc-2860-e053-6605fe0a460a 5
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing., file e4233f15-0812-2860-e053-6605fe0a460a 4
null, file e4233f19-6176-2860-e053-6605fe0a460a 4
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study, file e4233f17-86cd-2860-e053-6605fe0a460a 3
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays, file e4233f19-7854-2860-e053-6605fe0a460a 2
AKT1(E17K) in human solid tumours, file e4233f14-f033-2860-e053-6605fe0a460a 1
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors., file e4233f14-f5b7-2860-e053-6605fe0a460a 1
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series., file e4233f15-6ddd-2860-e053-6605fe0a460a 1
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control, file e4233f19-1e3a-2860-e053-6605fe0a460a 1
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients, file e4233f19-26b3-2860-e053-6605fe0a460a 1
Totale 341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 1 0 2
2019/202017 2 0 0 0 0 0 0 0 0 11 4 0
2020/202147 0 0 0 0 2 4 2 3 12 2 8 14
2021/202289 4 4 5 4 7 5 2 4 2 4 21 27
2022/2023146 4 2 2 2 3 15 23 15 22 29 25 4
2023/202436 11 7 3 8 7 0 0 0 0 0 0 0
Totale 341